Issues of Cancer Biology and Biomedicine with Symmetry
A special issue of Symmetry (ISSN 2073-8994). This special issue belongs to the section "Life Sciences".
Deadline for manuscript submissions: closed (20 November 2022) | Viewed by 3115
Special Issue Editors
2.Department of Chemistry, University of South Florida, 4202 E. Fowler Ave., Tampa, FL 33620, USA
Interests: anticancer agents; antivirals; Parkinson’s disease; organic synthesis; drug design
Special Issues, Collections and Topics in MDPI journals
Interests: medicinal chemistry; drug discovery; bioinformatics
Special Issue Information
Dear Colleagues,
Symmetry and symmetry breaking could provide an innovative pathway to a solution for problems in the field of cancer biology. The term “symmetry” in biological systems is generally used in reference to well-controlled biological processes that include cell division, movement, polarity, and development. In cancer biology, numerous biological signals such as cytokines, chemokines, and reactive species can cause a shift from symmetry to symmetry breaking, which disrupts the cellular homeostasis, triggering inflammation and associated tumorigenesis and vice versa. Thus, it would be highly desirable to better understand the role of symmetry disruption in the cycle between inflammation and cancer at both molecular and cellular levels. In particular, restoring homeostasis by targeting cell division, movement, or polarity, resolving dysregulated inflammation, and abolishing the formation of the tumor microenvironment of interest as promising directions.
In this Special Issue of Symmetry, we would like to invite contributions from all research fields, including cancer biology, chemistry, nutrition science, biomedicine, cancer-associated inflammation, antioxidant research, and any other relevant fields, regardless of the discipline. Contributions may be in the form of original research articles, reviews, or shorter perspective articles. Topics relevant to the mechanisms of anti-inflammation, anti-cancer, and anti-oxidation are all welcome.
Prof. Dr. Ralph Salvatore
Dr. Sudip Paul
Prof. I-Ta Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Symmetry is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer biology
- inflammation
- antioxidant
- biomedicine
- nutrition science
